-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Adma Biologics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2016 to Q4 2024.
- Adma Biologics, Inc. Cost of Revenue for the quarter ending December 31, 2024 was $54.2M, a 26.6% increase year-over-year.
- Adma Biologics, Inc. Cost of Revenue for the twelve months ending December 31, 2024 was $207M, a 22.2% increase year-over-year.
- Adma Biologics, Inc. annual Cost of Revenue for 2024 was $207M, a 22.2% increase from 2023.
- Adma Biologics, Inc. annual Cost of Revenue for 2023 was $169M, a 42.5% increase from 2022.
- Adma Biologics, Inc. annual Cost of Revenue for 2022 was $119M, a 48.9% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)